期刊文献+

HPLC-UV法测定人血浆中青霉胺浓度 被引量:8

HPLC-UV determination of penicillamine in human plasma
下载PDF
导出
摘要 目的建立人血浆中青霉胺浓度的HPLC测定方法,并用于人体药动学试验中青霉胺血药浓度测定。方法取血浆样品加入衍生化试剂DTNB,室温反应5 min,10%的高氯酸溶液沉淀蛋白,上清液进样分析。色谱柱:岛津VP-ODS C18色谱柱(150 mm×4.6 mm,5μm),流动相为甲醇-0.05 mol.L-1醋酸钠缓冲溶液(12:88),流速1.0 ml.min-1,检测波长320 nm,柱温25℃,进样量20μl。结果血浆中青霉胺在0.1~10.0 mg.L-1浓度范围内线性关系良好,定量下限为0.1 mg.L-1(S/N>10,n=5;RSD=6.4%,准确度为94.2%),在低、中、高浓度血浆样品日内、日间RSD均小于6%,准确度在92%~96%范围内,提取回收率>60%,且稳定(RSD<10%),符合生物样品分析要求。结论所建立的HPLC法样品前处理简便、操作简便、能满足青霉胺在人体内的药代动力学研究。 Aim To develop a HPLC-UV method for the determination of penicillamine in human plasma and apply it to a pharmacokinetic study of penicillamine in healthy Chinese volunteers.Method Plasma samples were added with derivatization reagent 5,5′-dithiobis(2-nitrobenzoic acid),and then vortexed and incubated at room temperature for 5 min before acidification with 10% perchloric acid to deposit proteins.The supernatant liquid was injected into the HPLC system.Shimadzu VP-ODS C18 column(150 mm× 4.6 mm,5 μm) was used.The chrom-atographic conditions were as follows: The mobile phase was methanol-0.05 mol·L-1 sodium acetate solution(12: 88),the flow rate was 1 ml·min-1,the column temperature was at 25 ℃ and the UV detection wavelength was set at 320 nm,the injection volume was 20 μl.Result Calibration curve was linear over the range of 0.1~10.0 mg·L-1.The lower limit of quantification was 0.1 mg·L-1.The extraction recoveries were higher than 60%.The intra-and inter-day precision(RSD %) were lower than 6%.Conclusion A simple,rapid,accurate and precise HPLC method for determining penicillamine in human plasma is successfully developed and validated and successfully applied to a pharmacokinetic study of penicillamine in healthy Chinese volunteers.
出处 《中国药理学通报》 CAS CSCD 北大核心 2013年第4期585-588,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81001592) 教育部科学技术重点项目(No 210101) 安徽高校省级自然科学研究重点项目资助(No KJ2010A210 KJ2012A186)
关键词 青霉胺 人血浆 血药浓度 HPLC 测定 药代动力学 penicillamine human plasma plasma concentration HPLC determination pharmacokinetics
  • 相关文献

参考文献15

  • 1Chapela R, Zuniga G, Selman M. D-penicillamine in the therapy of fi- brotic lung diseases [Jl. Ira J Clin Pharmacol Ther Toxicol , 1986, 24 (1): 16-7.
  • 2Davis P. Penicillamine metal chelates and their possible importance in rheumatoid arthritis-a brief review [J]. Clin Invest Med, 1984, 7(1) : 41 -4.
  • 3Kang B, Veres-Thomer C, Heredia R, et al. Successful treatment of far-advanced progressive systemic sclerosis by D-penicillamine [ J ]. JAllergy Clin Immunol, 1982, 69(3 ) : 297 - 305.
  • 4Roelofs R I, Saavedra De Arango G, Law P K, et al. Treatment of Ducherme' s muscular dystrophy with penieillamine. Results of a doub- le-blind trim [J]. Arch Neurol, 1979, 36(5) : 266 -8.
  • 5Zhang Z D,Baeyens W R,Zhang X R,et al. HPLC determination of penicillamine in human urine applying a chemiluminescent detection system[ J ]. Biomed Chromatogr ,1997,11 (2) :113 -4.
  • 6Haj-Yehia A I, Benet L Z. 2-(4-N-Maleimidophenyl )-6-methoxy- benzofuran: a superior derivatizing agent for fluorimetrie determination of aliphatiethiols by high-performanceliquidchromatography [ J ]. J Chromatogr B Biomed Appl, 1995, 666( 1 ): 45-53.
  • 7Nakashima K, Ishimam T, Kuroda N, Akiyama S. High-performance liquid chromatographic separation of penicillamine enantiomers labelled with N-[4-(6-dimethylamino-2-benzofuranyl ) phenyl ] maleimide on a chiral stationary phase[J]. Biomed Chromatogr,1995, 9(2) : 90 -3.
  • 8Mamela K M, Isomaki H, Takalo R, Vapaatalo H. Determination of D-penici|lamine with an amino acid analyser using fluorescence detec- tion [J]. J Chromatogr, 1986, 380(1) : 170 -6.
  • 9Yusof M, Neal R, Aykin N, Ercal N. High performance liquid chro- matography analysis of D-penicillamine by derivatization with N-( 1- pyrenyl) maleimide ( NPM ) [ J ]. Biomed Chromatogr, 2000, 14 (8) : 535 -40.
  • 10Wakabayashi H, Yamato S, Nakajima M, Shirnada K. Application of an electrochemical detector with a graphite electrode to liquid chroma- tographic determination of penicillamine and eaptopril in biological samples [J]. J Pharm Biomed Anal, 1994, 12(9) : 1147 -52.

二级参考文献14

  • 1巫国谊,赵有蓉.N-乙酰半胱氨酸的药理作用机制研究进展[J].现代医药卫生,2004,20(19):2001-2002. 被引量:16
  • 2杜小莉,朱珠,傅强,李大魁.HPLC测定还原型谷胱甘肽的血浆浓度[J].中国药学杂志,2005,40(6):454-457. 被引量:13
  • 3DIMITRIOS T, JORG S, MILOS I,et al. Analysis of cysteine and N-acetylcysteine in human plasma by high-performance liquid chromatography at the basal state and after oral administration of N-acetylcysteine [ J]. J Chromatogr B, 1998,708:55-60.
  • 4HEYDEN Y V, MANGELINGS D, BREMPT J V, et al. Development and validation of an HPLC method with post-column derivatisation for assay of N-acetylcysteine in plasma [ J]. ACTA Chromatographica, 2004,14 : 149-163.
  • 5MEISTER A, ANDERSON M E. Glutathione [ J 1. Annu Ren Biochem, 1983,52:711.
  • 6Meister A, Anderson ME. Glutathione [ J ]. Annu Rev Biochem, 1983,52: 711.
  • 7Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma[ J ]. Analytical Biochemistry, 1992,200(2):218.
  • 8Abei S, Assereto R, Lauterburg BH. High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine [ J] . Eur J Clini Invest ,1991,21(1) :103.
  • 9Burgund JM, Lauterburg BH. Decreased production of glutathione in patients with cirrhosis[J]. Eur J Clini Invest, 1987,17(5) :408.
  • 10Michelet F, Gueguen R, Leroy P, et al. Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits[J]. Clin Chem, 1995,41(10): 1509.

共引文献15

同被引文献59

引证文献8

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部